The US Food and Drug Administration (FDA) recently cleared the myBioness mobile app for use with the Bioness L300 Go System, an FES (Functional Electrical Stimulation) device which improves muscle strength in patients with multiple sclerosis (MS) who have problems walking.
The L300 Go System is approved to help adults and children with foot drop, and assists adults with knee flexion or extension problems caused by muscle weakness. It is the first electrical stimulation device to offer 3D motion detection of walking and muscle activity. Electrical stimulation of leg muscles helps MS patients who struggle with foot drop to walk with greater ease and may lower their risk of falling.
The L300 Go System uses data from a three-axis gyroscope and accelerometer to generate 3D motion detection of walking and associated muscle activity. The system monitors patient movement and applies electrical stimulation as needed during walking. “Technological innovations including 3D motion detection and multi-channel stimulation work together to improve treatment efficiency and promote patient mobility,” Todd Cushman, President and Chief Executive Officer of Bioness, said.
The mobile app — which is expected to be released shortly — helps to control the L300 Go System, allowing users to change between stimulation models, as well as to adjust pre-determined settings to fit their personal needs. It offers users the ability to track activity, set personal goals, and review progress over time. Bioness plans to release the app this spring, initially for use by iOS mobile devices such as iPhones and iPads.
Source: MS-UK 11/04/18